Propranolol

Source: Wikipedia, the free encyclopedia.

Propranolol
Clinical data
Pronunciation/prˈprænəˌlɒl/
Trade namesInderal, others
Other namesAY-20694; AY20694
AHFS/Drugs.comMonograph
License data
Pregnancy
category
  • AU: C
Antihypertensive agent; Anxiolytic
ATC code
Legal status
Legal status
MetabolitesN-Desisopropylpropranolol; 4'-Hydroxypropanolol[2]
Elimination half-life~4 hours (range 3–8 hours)[1][4][2]
Duration of actionUp to 12 hours[5]
ExcretionUrine: 91%[4][2]
Identifiers
  • (RS)-1-(propan-2-ylamino)-3-(1-naphthyloxy)propan-2-ol
JSmol)
ChiralityRacemic mixture
Melting point96 °C (205 °F)
SMILES
  • OC(COC1=C2C=CC=CC2=CC=C1)CNC(C)C
  • InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3 checkY
  • Key:AQHHHDLHHXJYJD-UHFFFAOYSA-N checkY
  (verify)

Propranolol is a medication of the

intravenous injection.[6][2] The formulation that is taken orally comes in short-acting and long-acting versions.[6] Propranolol appears in the blood after 30 minutes and has a maximum effect between 60 and 90 minutes when taken orally.[6][10]

Common

Propranolol was patented in 1962 and approved for medical use in 1964.

generic medication.[6] In 2022, it was the 77th most commonly prescribed medication in the United States, with more than 8 million prescriptions.[15][16]

Medical uses

extended-release
propranolol
A mixture of 20 mg and 10 mg extended-release propranolol tablets
Propranolol blister pack

Propranolol is used for treating various conditions, including:

Cardiovascular

While once a first-line treatment for

type 2 diabetes.[17]

Propranolol is not recommended for the treatment of

high blood pressure by the Eighth Joint National Committee (JNC 8) because a higher rate of the primary composite outcome of cardiovascular death, myocardial infarction, or stroke compared to an angiotensin receptor blocker was noted in one study.[18]

Propranolol is occasionally used to treat

palpitations, and this may interfere with a positive feedback loop to indirectly reduce psychological anxiety.[21]

A 2025

bias of those studies, was limited.[21] Findings were similar in a previous 2016 systematic review and meta-analysis.[22]

Other beta blockers that have been used to treat anxiety disorders besides propranolol include atenolol, betaxolol, nadolol, oxprenolol, and pindolol.[21][23]

Some experimentation has been conducted in other psychiatric areas:[24]

Post-traumatic stress disorder and phobias

Propranolol is being investigated as a potential treatment for PTSD.

social phobia.[19] It has also been found to be helpful for some individuals with misophonia.[33]

Ethical and legal questions have been raised surrounding the use of propranolol-based medications for use as a "memory damper", including altering memory-recalled evidence during an investigation, modifying the behavioral response to past (albeit traumatic) experiences, the regulation of these drugs, and others.[34] However, Hall and Carter have argued that many such objections are "based on wildly exaggerated and unrealistic scenarios that ignore the limited action of propranolol in affecting memory, underplay the debilitating impact that PTSD has on those who suffer from it, and fail to acknowledge the extent to which drugs like alcohol are already used for this purpose".[35]

Other uses

Propranolol may be used to treat severe infantile hemangiomas (IHs). This treatment shows promise as being superior to corticosteroids when treating IHs. Extensive clinical case evidence and a small controlled trial support its efficacy.[41]

Propranolol is useful in the treatment of acute

sympathomimetics like amphetamine, methamphetamine, cocaine, ephedrine, and pseudoephedrine, including reducing elevations in heart rate and blood pressure caused by these agents.[42][43] Other beta blockers are also used.[42][43] However, the controversial yet possible phenomenon of "unopposed α-stimulation" with administration of selective beta blockers to block non-selective sympathomimetics potentially makes dual alpha-1 and beta blockers like labetalol and carvedilol more favorable for such purposes than selective beta blockers like propranolol.[42][43] The rate of unopposed α-stimulation with selective beta blockers has been reported to be 0.4%,[42] whereas no cases of unopposed α-stimulation have been reported with dual alpha and beta blockers like labetalol.[43]

Available forms

Propranolol is available in the form of 10, 20, 40, 60, and 80 mg (as propranolol hydrochloride) oral tablets, among other formulations.[1][4]

Contraindications

sick sinus syndrome, atrioventricular block (second- or third-degree), circulatory shock, and severe hypotension (low blood pressure).[44]

Propranolol should be used with caution in people with:[44]

Side effects

Pregnancy and lactation

Propranolol, like other beta-blockers, is classified as

premature birth. The newborn may experience additional adverse effects such as low blood sugar and a slower than normal heart rate.[45]

Most β-blocking agents appear in the milk of lactating women. However, propranolol is highly bound to proteins in the bloodstream and is distributed into breast milk at very low levels.[46] These low levels are not expected to pose any risk to the breastfeeding infant, and the American Academy of Pediatrics considers propranolol therapy "generally compatible with breastfeeding."[45][46][47][48]

Overdose

Propranolol

ventricular arrhythmias, or cardiogenic shock which may ultimately culminate in bradycardic PEA.[50]

Interactions

Pharmacodynamic interactions

Since beta blockers are known to relax the cardiac muscle and constrict the smooth muscle, they have an additive effect with other drugs that decrease blood pressure or decrease cardiac contractility or conductivity.

indomethacin specifically may reduce the efficacy of propranolol in decreasing heart rate and blood pressure.[1]

Effects of drugs on propranolol

Propranolol is

The CYP2D6 inhibitor quinidine has been found to increase propranolol levels by 2- to 3-fold.

Aluminum hydroxide gel may decrease propranolol levels.[1] Alcohol may increase propranolol levels.[1]

Effects of propranolol on other drugs

Propranolol has been found to increase

area-under-the-curve levels by more than 3-fold.[1] It has been found to increase lidocaine levels by 1.3-fold.[1] The drug has been found to increase peak and area-under-the-curve levels of nifedipine by 1.6-fold and 1.8-fold, respectively.[1] Propranolol decreases theophylline clearance by 30 to 52%.[1] Propranolol inhibits the metabolism of the benzodiazepine diazepam and can increase exposure to diazepam.[1] Conversely, propranolol does not affect various other benzodiazepines including oxazepam, triazolam, lorazepam, and alprazolam.[1] High-dose long-acting propranolol has been found to increase thioridazine levels by 1.6- to 4.7-fold and levels of its metabolite mesoridazine by 1.3- to 3.1-fold.[1] Propranolol decreased lovastatin or pravastatin area-under-the-curve levels by 18 to 23% but did not affect fluvastatin.[1] It may decrease triiodothyronine (T3) levels when taken with thyroxine (T4).[1] Propranolol has been found to increase the bioavailability and effects of warfarin.[1]

Pharmacology

Pharmacodynamics

Propranolol activities
Site Ki (nM) Species Ref
5-HT1A 55–272 Human [55][56]
5-HT1B 56–85 Rat [57][58]
5-HT1D 4,070 Pig [59]
5-HT2A 4,280 Human [60]
5-HT2B 457–513 (+)
166–316 ()
Human
Human
[61]
[61]
5-HT2C 61,700 (+)
5,010 ()
736–2,457
Human
Human
Rodent
[61]
[61]
[62][56]
5-HT3 >10,000 Human [63]
α1 ND ND ND
α2 1,297–2,789 Rat [64]
β1 0.02–2.69 Human [65][66]
β2 0.01–0.61 Human [65][66]
β3 450 Mouse [67]
D1
>10,000 Human [56]
D2
>10,000 Human [56]
H1
>10,000 Human [68]
SERTTooltip Serotonin transporter 3,700 Rat [69]
NETTooltip Norepinephrine transporter 5,000 (
IC50
Tooltip Half-maximal inhibitory concentration)
Rat [70]
DATTooltip Dopamine transporter 29,000 (IC50) Rat [70]
VDCC
Tooltip Voltage-dependent calcium channel
>10,000 Rat [71]
Notes: Values are Ki (nM), unless otherwise noted. The smaller the value, the more avidly the drug binds to the site. Refs: [72][73]

Propranolol is classified as a competitive non-cardioselective sympatholytic

overdose).[75] Propranolol can cross the blood–brain barrier and exert effects in the central nervous system in addition to its peripheral activity.[19]

In addition to blockade of

5-HT1A, 5-HT1B, and 5-HT2B receptors.[77][78][79][61] The latter may be involved in the effectiveness of propranolol in the treatment of migraine at high doses.[61]

Both enantiomers of propranolol have a local anesthetic (topical) effect, which is normally mediated by blockade of voltage-gated sodium channels. Studies have demonstrated propranolol's ability to block cardiac, neuronal, and skeletal voltage-gated sodium channels, accounting for its known membrane stabilizing effect and antiarrhythmic and other central nervous system effects.[80][81][82]

Mechanism of action

Propranolol is a non-selective beta receptor antagonist.[74] This means that it does not have preference to β1 or β2 receptors. It competes with sympathomimetic neurotransmitters for binding to receptors, which inhibits sympathetic stimulation of the heart. Blockage of neurotransmitter binding to β1 receptors on cardiac myocytes inhibits activation of adenylate cyclase, which in turn inhibits cAMP synthesis leading to reduced Protein kinase A (PKA) activation. This results in less calcium influx to cardiac myocytes through voltage-gated L-type calcium channels meaning there is a decreased sympathetic effect on cardiac cells, resulting in antihypertensive effects including reduced heart rate and lower arterial blood pressure.[4] Blockage of neurotransmitter binding to β2 receptors on smooth muscle cells will increase contraction, which will increase hypertension.

Pharmacokinetics

Absorption

Propranolol is rapidly and completely

interindividual variability in pharmacokinetics, with propranolol levels varying 20-fold in different individuals.[85]

Distribution

The

lipophilic drug achieving high concentrations in the brain.[3][86] The brain-to-blood ratio of propranolol was 33:1 in one study, whereas the ratio for the peripherally selective beta blocker atenolol was 0.2:1 in the same study.[86]

Metabolism

Propranolol undergoes

elimination half-life than propranolol, is also pharmacologically active.[4][2]

Elimination

Propranolol is eliminated in urine.[4][2] Approximately 91% of an oral dose of propranolol is eliminated in urine as 12 metabolites.[4][2] Only about 1 to 4% of propranolol is excreted unchanged in urine or feces.[2]

The

duration of action of a single oral dose is longer than the half-life and may be up to 12 hours if the single dose is high enough (e.g., 80 mg).[5]

Pharmacogenomics

There were no significance differences in area-under-the-curve levels of propranolol in

extensive metabolizers.[53] However, area-under-the-curve propranolol levels were ~2.5-fold higher in Caucasian CYP2D6 poor metabolizers or Chinese people with a non-functional CYP2D6 gene.[53] The contribution of CYP2D6 to the metabolism of propranolol is less than with metoprolol and is described as only "marginal".[53]

Chemistry

Propranolol is highly

log P of propranolol is 3.0 to 3.48 and its predicted log P ranges from 2.20 to 3.10.[2][87][4][5][88]

History

James W. Black developed propranolol in the 1960s.[3][89] It was the first beta-blocker effectively used in the treatment of coronary artery disease and hypertension.[90]

Newer, more cardio-selective beta blockers (such as bisoprolol, nebivolol, carvedilol, or metoprolol) are used preferentially in the treatment of hypertension.[90]

Society and culture

Performance enhancement

In a 1987 study by the International Conference of Symphony and Opera Musicians, it was reported that 27% of interviewed members said they used beta blockers such as propranolol for musical performances.[91] For about 10 to 16% of performers, their degree of stage fright is considered pathological.[91][92] Propranolol is used by musicians, actors, and public speakers for its ability to treat anxiety symptoms activated by the sympathetic nervous system.[93] It has also been used as a performance-enhancing drug in sports where high accuracy is required, including archery, shooting, golf,[94] and snooker.[94] In the 2008 Summer Olympics, 50-metre pistol silver medalist and 10-metre air pistol bronze medalist Kim Jong-su tested positive for propranolol and was stripped of his medals.[95]

Brand names

Propranolol was first marketed under the brand name Inderal, manufactured by ICI Pharmaceuticals (now AstraZeneca), in 1965. "Inderal" is a quasi-anagram of "Alderlin", the trade name of pronethalol (which propranolol replaced); both names are an homage to Alderley Park, the ICI headquarters where the drugs were first developed.[96]

Propranolol is also marketed under brand names Avlocardyl, Deralin, Dociton, Inderalici, InnoPran XL, Indoblok,[97] Sumial, Anaprilin, and Bedranol SR (Sandoz). In India, it is marketed under brand names such as Ciplar and Ciplar LA by Cipla. Hemangeol, a 4.28 mg/mL solution of propranolol, is indicated for the treatment of proliferating infantile hemangioma.[98]

References

  1. ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag ah ai aj ak al am an ao ap aq ar https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/016418s080,016762s017,017683s008lbl.pdf
  2. ^
    PMID 32286940
    .
  3. ^ .
  4. ^ a b c d e f g h i j k l m n "Propranolol". www.drugbank.ca. Retrieved 31 January 2019.
  5. ^ a b c "Propranolol". pubchem.ncbi.nlm.nih.gov. Retrieved 31 January 2019.
  6. ^ a b c d e f g h i j k "Propranolol hydrochloride". Monograph. The American Society of Health-System Pharmacists. Archived from the original on 1 January 2015. Retrieved 1 January 2015.
  7. ^
    PMID 17092192
    .
  8. .
  9. .
  10. from the original on 24 March 2017.
  11. ^ "Prescribing medicines in pregnancy database". Australian Government. 3 March 2014. Archived from the original on 8 April 2014. Retrieved 22 April 2014.
  12. from the original on 14 February 2017.
  13. .
  14. . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
  15. ^ "The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
  16. ^ "Propranolol Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Retrieved 30 August 2024.
  17. National Institute for Health and Clinical Excellence. Archived from the original
    on 24 September 2006. Retrieved 11 October 2009.
  18. .
  19. ^ .
  20. .
  21. ^ .
  22. .
  23. .
  24. .
  25. .
  26. .
  27. .
  28. ^ "Doctors test a drug to ease traumatic memories - Mental Health - NBC News". NBC News. Archived from the original on 12 November 2013. Retrieved 30 June 2007.
  29. PMID 17588604
    .
  30. .
  31. ^ "DocFilm – DW". dw.com. Retrieved 2 August 2023.
  32. S2CID 3064619
    .
  33. .
  34. ^ Kolber AJ (2006). "Therapeutic Forgetting: The Legal and Ethical Implications of Memory Dampening". Vanderbilt Law Review, San Diego Legal Studies Paper No. 07-37. 59: 1561.
  35. S2CID 27063524
    .
  36. .
  37. .
  38. from the original on 24 March 2017.
  39. ^ Chan C, Goadsby PJ (26 September 1996). Silberstein SD (ed.). "Primary exercise headache". MedLink.
  40. S2CID 248375711
    .
  41. .
  42. ^ .
  43. ^ .
  44. ^ a b c Rossi S, ed. (2006). Australian Medicines Handbook. Adelaide: Australian Medicines Handbook.
  45. ^ .
  46. ^
    National Library of Medicine
    Toxicology Data Network. Retrieved 25 February 2013.
  47. .
  48. .
  49. .
  50. .
  51. ^ .
  52. .
  53. ^ .
  54. .
  55. .
  56. ^ .
  57. .
  58. .
  59. .
  60. .
  61. ^ .
  62. .
  63. .
  64. .
  65. ^ .
  66. ^ .
  67. .
  68. .
  69. .
  70. ^ .
  71. .
  72. ^ Roth BL, Driscol J. "PDSP Ki Database". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 14 August 2017.
  73. ^ https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25761
  74. ^
    PMID 28431779. {{cite book}}: |journal= ignored (help
    )
  75. .
  76. ^ .
  77. . Table II. Affinities of Selected Phenalkylamines for 5-HT1 and 5-HT2 Binding Sites
  78. .
  79. .
  80. .
  81. .
  82. S2CID 631197. Archived from the original
    (PDF) on 20 February 2019.
  83. .
  84. .
  85. .
  86. ^ .
  87. .
  88. ^ "b-Propranolol". ChemSpider. 10 June 2024. Retrieved 22 June 2025.
  89. PMID 14132613
    .
  90. ^ .
  91. ^ a b Fishbein M, Middlestadt SE, Ottati V, Straus S, Ellis A (1988). "Medical problems among ICSOM musicians: overview of a national survey". Med Probl Perform Artist. 3: 1–8.
  92. .
  93. .
  94. ^ a b Tim Glover. "Golf: O'Grady says players use beta-blockers: Drugs 'helped win majors'". The Independent. Archived from the original on 25 September 2015. Retrieved 28 March 2017.
  95. ^ Scott M (15 August 2008). "Olympics: North Korea's Kim Jong-su loses medals after positive drugs test". The Guardian. Guardian News and Media Limited. Retrieved 7 March 2018.
  96. PMID 16502872
    .
  97. ^ "Indoblok Tablet - Product - TabletWise.com". www.tabletwise.com. Retrieved 15 October 2022.
  98. ^ "Hemangeol - Food and Drug Administration" (PDF). 1 March 2014. Archived (PDF) from the original on 2 April 2015. Retrieved 23 March 2015.

Further reading